New Atlas

Man clutching his chest from acute pain

New heart attack detector gives results in minutes, not hours

Someone presenting to the emergency room with a suspected heart attack will undergo a number of standard blood tests to determine heart muscle damage. The problem is that it can take one or two hours to receive the results. Now, Johns Hopkins University researchers have led the design of a tiny chip that diagnoses heart attack by detecting these important biomarkers in minutes rather than hours, even if they are present at very low concentrations. The researchers foresee an at-home heart attack detector in the future.

New heart attack detector gives results in minutes, not hours Read more

Neurons inside human brain,Neuronal network with electrical activity of neuron cells,3d rendering

Synapse-restoring pill set for human trials as novel schizophrenia treatment

Spinogenix is the American company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic lateral sclerosis (ALS). Having been granted approval from the Australia Human Research Ethics Committee (HREC), it is now actively enrolling participants for its Phase 2 clinical trial to evaluate the safety, effectiveness, tolerability, and pharmacodynamics of once-a-day SPG302 as a treatment for schizophrenia.

Synapse-restoring pill set for human trials as novel schizophrenia treatment Read more

Green ammonia plant

World’s first green ammonia plant is now open for business in Denmark

The new plant – located in Ramme, Denmark – is said to be capable of producing 5,000 tons of green ammonia per year, entirely from solar and wind energy. Topsoe reports that this effort will prevent 8,200 tons of carbon dioxide emissions annually. Gray ammonia production – which uses fossil fuels – is currently the norm around the globe, and accounts for about 1.2% of all carbon dioxide emissions.

World’s first green ammonia plant is now open for business in Denmark Read more

Honeycomb

Manuka honey reduces breast cancer cell growth by 84% in preliminary studies

Manuka honey is produced from the nectar collected by honey bees when they pollinate the mānuka, a species of tea tree indigenous to New Zealand and southeast Australia. Now, preliminary studies by researchers at UCLA have found that this nutraceutical might aid in breast cancer prevention and treatment. The honey-treated mice showed significantly suppressed tumor growth compared to controls. Overall, it inhibited the growth and progression of an established human breast cancer tumor by 84% without affecting healthy cells.

Manuka honey reduces breast cancer cell growth by 84% in preliminary studies Read more

Ocean Energy grid-scale wave energy generator Hawaii

Revolutionary grid-scale wave energy generator deployed in Hawaii

Ocean Energy has deployed its 826-tonne wave energy converter buoy OE-35 at the US Navy’s Wave Energy Test Site off the coast of the island of Oahu ahead of it being hooked up to Hawaii’s electricity grid. With a potential output of 1.25 MW, OE-35 harnesses energy from the waves using a remarkable double-flow air system.

Revolutionary grid-scale wave energy generator deployed in Hawaii Read more

Fervo Energy geothermal plant

World’s biggest geothermal power purchase agreement completed in western U.S.

It’s only been one year since Fervo Energy unveiled a novel concept in geothermal energy harvesting at its Project Red pilot plant in Nevada. Now the company has signed a 15-year agreement with Southern California Edison to provide 320 MW of power to the utility, which will power about 350,000 homes. The power will be provided by Fervo’s Cape Station project that is currently being built in southwest Utah, with the first 70 MW coming online in 2026 and the balance clicking on in 2028.

World’s biggest geothermal power purchase agreement completed in western U.S. Read more

Sick woman, stomach pain and hands on abdomen

U.K. researchers identify and treat major cause of inflammatory bowel disease

For the first time, a major trigger in inflammatory bowel disease (IBD) and related conditions has been identified, and existing drugs can stamp it out, in what scientists call a “massive step” in successfully treating these debilitating chronic conditions. Researchers at the Francis Crick Institute, in collaboration with University College London (UCL) and Imperial College London (ICL), have uncovered a problem gene enhancer that stimulates action along a specific biological pathway that causes IBD inflammation.

U.K. researchers identify and treat major cause of inflammatory bowel disease Read more

Cryo sauna for whole body cryotherapy

Cryo-cooling breakthrough slashes the energy cost of serious cold by 71%

Cryogenic cooling is used to preserve tissues, eggs, sperm, and embryos and CAT scanners, CERN’s massive particle accelerators, and the James Webb Space Telescope possible. It may also one day be the key to making fusion power or quantum computers a reality. However, it is also quite energy-intensive. Fortunately, researchers at the U.S.’s National Institute of Standards & Technology have recently discovered a way to reach near-absolute zero up to 3.5 times faster or using about 71% less energy.

Cryo-cooling breakthrough slashes the energy cost of serious cold by 71% Read more

A neuron or nerve cell is an electrically excitable cell

Breakthrough synapse-regenerating ALS pill moves to phase 2 human trials

Spinogenix, a clinical-stage biopharmaceutical company based in California, has developed SPG302, a unique once-a-day pill that regenerates the gaps, called synapses, between neurons to restore communication in ALS patients. Following promising results from clinical trials to evaluate the drug’s safety, the FDA has approved the company’s Investigational New Drug application, paving the way for further trials and a possible watershed moment in the treatment of the fatal disease.

Breakthrough synapse-regenerating ALS pill moves to phase 2 human trials Read more

Plant coming out of concrete

‘Absolute miracle’ breakthrough provides recipe for zero-carbon cement

Concrete is the world’s most used building material, and making it is a particularly dirty business – concrete production alone is responsible for about 8% of total global CO2 emissions. But according to new research from the University of Cambridge, throwing old concrete into steel-processing furnaces not only purifies iron but produces “reactivated cement” as a byproduct. If done using renewable energy, the process could make for completely carbon-zero cement.

‘Absolute miracle’ breakthrough provides recipe for zero-carbon cement Read more